Glucocorticoid therapy delays the clearance of SARS‐CoV‐2 RNA in an asymptomatic COVID‐19 patient
2020; Wiley; Volume: 92; Issue: 11 Linguagem: Inglês
10.1002/jmv.26086
ISSN1096-9071
AutoresShu‐Qing Ma, Jing Zhang, Yu‐Shan Wang, Jun Xia, Peng Liu, Hong Luo, Ming‐Yi Wang,
Tópico(s)Long-Term Effects of COVID-19
ResumoJournal of Medical VirologyVolume 92, Issue 11 p. 2396-2397 LETTER TO THE EDITOR Glucocorticoid therapy delays the clearance of SARS-CoV-2 RNA in an asymptomatic COVID-19 patient Shu-Qing Ma, Shu-Qing Ma Department of Central Lab, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University, Weihai, Shandong, ChinaSearch for more papers by this authorJing Zhang, Jing Zhang Department of Central Lab, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University, Weihai, Shandong, China Department of Infectious Diseases, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University, Weihai, Shandong, ChinaSearch for more papers by this authorYu-Shan Wang, Yu-Shan Wang School of Laboratory Medicine, Dalian Medical University, Dalian, Liaoning, ChinaSearch for more papers by this authorJun Xia, Jun Xia Department of Infectious Diseases, Weihai Chest Hospital, Weihai, Shandong, ChinaSearch for more papers by this authorPeng Liu, Peng Liu Department of Central Lab, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University, Weihai, Shandong, ChinaSearch for more papers by this authorHong Luo, Corresponding Author Hong Luo [email protected] School of Laboratory Medicine, Dalian Medical University, Dalian, Liaoning, China Correspondence Hong Luo, School of Laboratory Medicine, Dalian Medical University, 116044 Dalian, Liaoning, China. Email: [email protected] Ming-Yi Wang, Department of Central Lab, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University, 264200 Weihai, Shandong, China. Email: [email protected]Search for more papers by this authorMing-Yi Wang, Corresponding Author Ming-Yi Wang [email protected] orcid.org/0000-0002-7710-4743 Department of Central Lab, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University, Weihai, Shandong, China Correspondence Hong Luo, School of Laboratory Medicine, Dalian Medical University, 116044 Dalian, Liaoning, China. Email: [email protected] Ming-Yi Wang, Department of Central Lab, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University, 264200 Weihai, Shandong, China. Email: [email protected]Search for more papers by this author Shu-Qing Ma, Shu-Qing Ma Department of Central Lab, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University, Weihai, Shandong, ChinaSearch for more papers by this authorJing Zhang, Jing Zhang Department of Central Lab, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University, Weihai, Shandong, China Department of Infectious Diseases, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University, Weihai, Shandong, ChinaSearch for more papers by this authorYu-Shan Wang, Yu-Shan Wang School of Laboratory Medicine, Dalian Medical University, Dalian, Liaoning, ChinaSearch for more papers by this authorJun Xia, Jun Xia Department of Infectious Diseases, Weihai Chest Hospital, Weihai, Shandong, ChinaSearch for more papers by this authorPeng Liu, Peng Liu Department of Central Lab, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University, Weihai, Shandong, ChinaSearch for more papers by this authorHong Luo, Corresponding Author Hong Luo [email protected] School of Laboratory Medicine, Dalian Medical University, Dalian, Liaoning, China Correspondence Hong Luo, School of Laboratory Medicine, Dalian Medical University, 116044 Dalian, Liaoning, China. Email: [email protected] Ming-Yi Wang, Department of Central Lab, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University, 264200 Weihai, Shandong, China. Email: [email protected]Search for more papers by this authorMing-Yi Wang, Corresponding Author Ming-Yi Wang [email protected] orcid.org/0000-0002-7710-4743 Department of Central Lab, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University, Weihai, Shandong, China Correspondence Hong Luo, School of Laboratory Medicine, Dalian Medical University, 116044 Dalian, Liaoning, China. Email: [email protected] Ming-Yi Wang, Department of Central Lab, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University, 264200 Weihai, Shandong, China. Email: [email protected]Search for more papers by this author First published: 29 May 2020 https://doi.org/10.1002/jmv.26086Citations: 11Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES 1Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020; 382: 727-733. 10.1056/NEJMoa2001017 CASPubMedWeb of Science®Google Scholar 2Zhang C, Huang S, Zheng F, Dai Y. Controversial treatments: an update understanding of the coronavirus disease 2019. J Med Virol. 2020. http://doi.org/10.1002/jmv.25788 Google Scholar 3 New coronavirus pneumonia prevention and control program ( 7nd ed.) (in Chinese). National Health Commission of the People's Republic of China. March 4, 2020. http://www.nhc.gov.cn/xcs/zhengcwj/202003/46c9294a7dfe4cef80dc7f5912eb1989/files/ce3e6945832a438eaae415350a8ce964.pdf. Accessed March 3, 2020. Google Scholar 4 WHO. World Health Organization; Geneva: Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected. January 28, 2020. https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected. Accessed March 13, 2020. Google Scholar 5Han Y, Jiang M, Xia D, et al. COVID-19 in a patient with long-term use of glucocorticoids: a study of a familial cluster. Clin Immunol. 2020; 214:108413. 10.1016/j.clim.2020.108413 CASPubMedWeb of Science®Google Scholar 6Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA. 2020; 323(11): 1061-1069. 10.1001/jama.2020.1585 CASPubMedWeb of Science®Google Scholar 7Wu J, Liu J, Li S, et al. Detection and analysis of nucleic acid in various biological samples of COVID-19 patients. Travel Med Infect Dis. 2020. http://doi.org/10.1016/j.tmaid.2020.101673 10.1016/j.tmaid.2020.101673 Web of Science®Google Scholar 8Jiang S, Liu T, Hu Y, et al. Efficacy and safety of glycocorticoids in the treatment of severe community-acquired pneumonia: a meta-analysis. Medicine (Baltimore). 2019; 98(26):e16239. 10.1097/MD.0000000000016239 PubMedWeb of Science®Google Scholar 9Isidori AM, Pofi R, Hasenmajer V, Lenzi A, Pivonello R. Use of glucocorticoids in patients with adrenal insufficiency and COVID-19 infection. Lancet Diabetes Endocrinol. 2020; 8: 472-473. 10.1016/S2213-8587(20)30149-2 CASPubMedWeb of Science®Google Scholar Citing Literature Volume92, Issue11Special Issue on New coronavirus (2019‐nCoV or SARS‐CoV‐2) and the outbreak of the respiratory illness (COVID‐19): Part‐VIINovember 2020Pages 2396-2397 ReferencesRelatedInformation
Referência(s)